Marksans Pharma (BSE: 524404, NSE: MARKSANS), headquartered in Mumbai, India, is actively engaged in R&D together with providing CRAMS to international pharmaceutical organizations. The company deals in OTC & prescription drugs which have wide ranging applications crosswise the fields such as Antibiotics, Oncology, Antidiabetic, Gastroenterology, Pain Management, Gynaecology, Cardiovascular, and among others.
The R&D capabilities of the company involve chemical synthesis, dossier development, formulation development, analytical development, process optimization and conducting stability studies. The corporation owns capabilities from Lab scale development to Pilot scale up also from commercializing the product for manufacturing on large scale to marketing internationally.
